
Personalised medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools. This innovative approach, which involves genetically modifying the cells of the immune system, is transforming the way we treat not only cancer, but also other diseases.
The CAR-T revolution is widely documented, with more than 1,000 clinical trials currently underway worldwide according to the ClinicalTrials platform. This reflects an enormous amount of scientific and medical interest.